€0.11
Your prediction
Description Expres2ion Biotech Holding Ab
Expres2ion Biotech Holding AB is a Swedish biotechnology company that specializes in the development of therapeutic proteins for human and veterinary medical use. The company currently has two proprietary technology platforms, the ExpreS2 system and the ExpreS10 system, which enable it to produce proteins with high yields and purity.
Expres2ion is focused on developing protein-based vaccines and immunotherapies for infectious diseases and cancer. Its lead product candidate, EBX-200, is a virus-like particle (VLP) vaccine for COVID-19 that is based on its ExpreS2 platform. The company is also developing a VLP vaccine for the Zika virus and a therapeutic cancer vaccine.
Expres2ion is listed on the Swedish stock exchange Nasdaq First North Growth Market under the ticker symbol "EXP2". The company was founded in 2010 and is headquartered in Lund, Sweden.
sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.Not a member yet? Sign up for free!
Financial data and news for Expres2ion Biotech Holding Ab
sharewise wants to provide you with the best news and tools for Expres2ion Biotech Holding Ab, so we directly link to the best financial data sources.